Evidence map›Paper›PMID 42547558›Full record

ArticleOncogene2026

Correction: MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma.

Hao Zhang, Xiangxu Kong, Haoran Qu, Yi Gao, Zhengyao Guan, Huaxin Zhou, Zhaoqing Yin, Kangping Lu, Wei Wang, Xiangyu Zhai and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hao Zhang *Organ Transplant Department, Qilu Hospital of Shandong University, Jinan, China.ORCID http://orcid.org/0000-0001-5330-8218
Xiangxu Kong *Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Haoran Qu *Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Yi GaoMedical Integration and Practice Center, Shandong University, Jinan, China.
Zhengyao GuanDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Huaxin ZhouDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Zhaoqing YinDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Kangping LuDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Wei WangMedical Integration and Practice Center, Shandong University, Jinan, China. jinglewei31@163.com.ORCID http://orcid.org/0009-0003-3994-2433
Xiangyu ZhaiDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. xiangyuzhai@email.sdu.edu.cn.ORCID http://orcid.org/0000-0001-7603-5769
Bin JinOrgan Transplant Department, Qilu Hospital of Shandong University, Jinan, China. jinbin@sdu.edu.cn.ORCID http://orcid.org/0000-0002-1411-2631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42547558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.